SINBON Non-audited Sales Revenue for January, 2012
The non-audited sales revenue for connector and cable assembly manufacturer, SINBON (TSEC#: 3023), in January is NT$710 million which is a decrease of 0.62% over last month’s revenue of NT$714 million but an increase of 4.68% over the revenue of the same period of 2011(NT$678 million).
According to SINBON, even though sales revenue for January has influenced by fewer working days due to Chinese New Year holiday, production plan upon customers’ demanding has planned in advance so the high demand from industrial control devices, solar, automotive and luxury devices can be met and sales revenue for January has reached over NT$710 million. As for the cable assembly for solar energy generating system, demand for the energy generating system is increased due to low cost of solar penal and subsidiaries on residential installations from the US Government, SINBON’s shipment of solar cable assembly has reached over NT$30 million in January. Industrial control device is also influenced by seasonal fluctuation in demand in North America, and shipment for January is increased over last month by NT$50 million. Shipment of automotive has benefited by legislation for enforcing installation of backing sensor on all new cars, demand for its cable assembly increases tremendously by NT$10 million over previous month. Increasing demand for interconnect cables for regular replacement and maintenance of message chairs and casino slot machines benefitted sales revenue for cable assemblies in luxury devices to increase by NT$20 million over last month.
Broken down by each field, the total shipments are: industrial control devices (12.53%); wireless communication (11.57%); data capture (11.04%); LED (9.60%); automotive (7.85%); luxuries devices (6.11%); medical devices (5.67%); wind energy (4.82%); solar related (4.69%); electronic peripheral components (26.12%).
DigiO2 International (digiO2), a subsidiary of SINBON, obtained the National Taiwan University Hospital (NTUH) telemedicine service contract in January 2012. According to the contract, digiO2 is to provide the remote patient monitoring system (or telehealth monitor), ECG monitor and pulse oximeter. Telemedicine is the use of medical information exchanged platform from one site to another via electronic communications to improve patients’ health status and it combined with online Personal Health Record (PHR) network and its supported biomedical sensors, which enables discharged patients to receive continuous caring and health counseling from the care givers without actual hospital visits. This also helps to reduce the recurrence of disease or serious complications as well as possible waste of valuable medical resources. DigiO2 has been recognized by the NTUH as one of the top industry leaders in telemedicine technology. Among offering telemedicine products, digiO2 also manufactures maternal fetal monitor device, baby sleep posture monitor, physiotherapy supplies and rehabilitation equipment.